Skip to content
Review Open access

Is drinking water with low PFAS a significant source of human exposure? Evidence summary.

Jul 2026 · Journal of Exposure Science and Environmental Epidemiology · 0 citations · 41 references
Medicine

TL;DR

Evidence is provided for a link between exposure to drinking water concentrations in the "low" range and measurable increases in blood PFAS, and certain compounds-particularly PFHxS-can materially contribute to circulating PFAS, especially among children and high-water-consumption subgroups.

Abstract

Background

Low-level contamination of drinking water with per- and polyfluoroalkyl substances (PFAS) is widespread, yet the extent to which such concentrations contribute to human PFAS body burdens remains incompletely characterized.

Objective

To synthesise evidence on the contribution of low-level PFAS in drinking water (defined as <100 ng/L for any individual PFAS) to PFAS concentrations in human blood.

Methods

We systematically searched Embase, MEDLINE, and Scopus using predefined logic grids. Inclusion criteria were original human studies reporting both drinking water PFAS and blood/serum/plasma PFAS concentrations with a focus on low-level water exposures. Ten studies (n = 4576 participants; 4590 blood samples; 1297 water samples) met criteria. Data were extracted on populations, sampling frames, PFAS species and concentrations, and key findings.

Results

Across studies from Sweden, China, USA, Germany, and Spain, "low-range" drinking water concentrations were associated with measurable increases in blood PFAS, with the most consistent and pronounced relationships observed for PFHxS. In children and high-consuming adults, water intake (≥7-8 cups/day or 1.8 Litres/day) and duration of residence on a supply amplified association. Evidence for contribution was most consistent at ~10-100 ng/L; below ~10 ng/L, associations were less consistent, though some data suggest PFHxS may influence serum levels even within this lower range. PFOA and PFOS showed weaker water-serum relationships at very low concentrations, compatible with greater contributions from legacy, non-water exposures. Heterogeneity in exposure assessment, timing, covariate control, and analytic reporting limited cross-study comparability.

Significance

Even when drinking water PFAS concentrations are low, certain compounds-particularly PFHxS-can materially contribute to circulating PFAS, especially among children and high-water-consumption subgroups. These findings support compound-specific risk assessment, re-examination of default relative source contribution (RSC) assumptions for sensitive groups, and targeted monitoring that pairs household-level water measurements with biomonitoring. Standardized methods and longitudinal designs are needed to refine low-range concentration-response relationships and cumulative exposure estimates. IMPACT STATEMENT By summarising 10 epidemiologic studies that investigated the contribution of low-level PFAS in drinking water to PFAS concentrations in human blood using rigorous methodology, our review provides compelling evidence for a link between exposure to drinking water concentrations in the "low" range and measurable increases in blood PFAS. Additionally, it suggests even when drinking water PFAS concentrations are low, certain compounds-particularly PFHxS-can materially contribute to circulating PFAS, especially among children and high water consumption subgroups. Given the nature of this evidence, there is a need for compound-specific risk assessment, re-examination of default relative source contribution assumptions for sensitive groups, and targeted monitoring that pairs household-level water measurements with biomonitoring.

Read PDF

Similar papers

Open access Jul 2026

Estimating drinking water PFAS exposures associated with serum clinical action levels using a probabilistic toxicokinetic model

Consumption of drinking water is a major and actionable human exposure pathway for per- and polyfluoroalkyl substances (PFAS), making it a focus of regulatory efforts. Population-based clinical guidelines recently established serum PFAS levels associated with health risk, but translating these into corresponding extern...

Greylin Nielsen, Emma S. Spady, Nicole S. Moody et al. · 0 citations
Open access Aug 2026

Serum concentrations of legacy, alternative, and precursor per- and polyfluoroalkyl substances: a descriptive analysis of premenopausal participants in the Canadian CARTaGENE cohort

The findings suggest that exposure to low levels of some alternative and precursor PFAS may be widespread in Canada and reinforce the role of pregnancy and breastfeeding as excretion pathways for legacy PFAS and support previous investigations demonstrating that exposure to some PFAS may be lower amongst financially di...

M. Borghese, Rebecca Lelievre, Sara Packull-McCormick et al. · 0 citations
Open access Jul 2026

PFAS 'forever' chemicals and active pharmaceutical ingredients (APIs) are widespread in UK fisheries.

Contaminants of Emerging Concern (CECs) pose a serious threat to global environmental and human health. Among the most concerning are per- and polyfluoroalkyl substances (PFAS) and pharmaceuticals, which have been detected at alarming concentrations in waterways and wildlife, including fish. However, there is limited i...

Alonn Castle, Marina Machidon, Cunyu Yan et al. · 0 citations
Open access Aug 2026

Multi-Media Exposure, Selective Accumulation and Health Risks of Organochlorine Pesticides in Human Serum under Post-Ban Conditions

Organochlorine pesticides (OCPs), despite being banned, persist in the environment and continue to pose potential risks to human health. This exploratory study investigated the concentrations of multiple OCPs in serum samples from 10 local residents and 52 surrounding environmental samples, including soil (n = 10), air...

Yu-Hao Fan, Lei Hou, Ke-Cheng Guo et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.